PHASE III, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Pregabalin in Prevention and Reduction of Oxaliplatin-induced Painful Neuropathy.

Trial Profile

PHASE III, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Pregabalin in Prevention and Reduction of Oxaliplatin-induced Painful Neuropathy.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 May 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Acronyms PreOx
  • Most Recent Events

    • 30 Sep 2016 Primary endpoint has not been met.
    • 30 Sep 2016 Results (n=162) presented at the 16th World Congress on Pain
    • 14 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top